Beijing Beilu Pharmaceutical (300016.SZ) obtained the registration certificate for iodoprolopran injection.

16:33 03/03/2026

Beilu Pharmaceutical (300016.SZ) announced that the company has received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for its injection of iopromide. The original research enterprise of iopromide injection is Bayer, Germany, and its indication is for diagnostic use.

Beijing Beilu Pharmaceutical (300016.SZ) announced that the company has received the Drug Registration Certificate for iodoproline injection issued by the National Medical Products Administration. The original research enterprise of iproline injection is Bayer, Germany, and it is used for diagnostic purposes.

MNSO (09896) spent 1.9132 million Hong Kong dollars to repurchase 56,600 shares on March 3rd.

Angang Steel (00347) appoints He Yongya as its legal process agent.

XINYI SOLAR (00968) will distribute a final dividend of 0.8 Hong Kong cents per share on July 3rd.

MNSO (09896) spent 1.9132 million Hong Kong dollars to repurchase 56,600 shares on March 3rd.

Angang Steel (00347) appoints He Yongya as its legal process agent.

XINYI SOLAR (00968) will distribute a final dividend of 0.8 Hong Kong cents per share on July 3rd.